Loading
companiesCompany
MGI Tech
Chinese sequencing-instrument maker (DNBSEQ), Illumina's main rival by volume, restricted in the US by the BIOSECURE Act.
Overview
MGI Tech, based in Shenzhen and listed as 688114.SS, is the Chinese sequencing instrument maker behind the DNBSEQ platforms, Illumina's main rival by volume, and it is restricted in the United States by the BIOSECURE Act. Its DNBSEQ-T7 and G400 instruments use DNA nanoball chemistry, dominate in China and are growing in Europe and emerging markets. OnCo links it to new short-read sequencing platforms and to the BIOSECURE Act term. Whether political restrictions in the United States slow its spread elsewhere, or simply split the sequencing market along geopolitical lines, is the open question. The BIOSECURE Act page carries the policy detail.
Similar pages
- CompanyElement Biosciences
Shares New short-read sequencing platforms and the tag supporting.
- CompanyUltima Genomics
Shares New short-read sequencing platforms and the tag supporting.
- CompanyWuXi XDC
Shares BIOSECURE Act and the tag supporting.
- TechnologyADC bioconjugation manufacturing (CDMOs)
Shares BIOSECURE Act and the tag supporting.